LymphedemaV1, Main, Exploration, bibRecord, 003E64

Stewart-Treves syndrome: pathogenesis and management.

Identifieur interne : 003E64 ( Main/Exploration ); précédent : 003E63; suivant : 003E65

Stewart-Treves syndrome: pathogenesis and management.

Auteurs : Amit Sharma [États-Unis] ; Robert A. Schwartz

Source :

Journal of the American Academy of Dermatology [ 1097-6787 ] ; 2012.

RBID : pubmed:22682884

Descripteurs français

KwdFr :
- Diagnostic différentiel, Humains, Hémangiosarcome (diagnostic), Hémangiosarcome (physiopathologie), Hémangiosarcome (étiologie), Lymphangiosarcome (diagnostic), Lymphangiosarcome (physiopathologie), Lymphangiosarcome (étiologie).
MESH :
- diagnostic : Hémangiosarcome, Lymphangiosarcome.
- physiopathologie : Hémangiosarcome, Lymphangiosarcome.
- étiologie : Hémangiosarcome, Lymphangiosarcome.
- Diagnostic différentiel, Humains.

English descriptors

KwdEn :
- Diagnosis, Differential, Hemangiosarcoma (diagnosis), Hemangiosarcoma (etiology), Hemangiosarcoma (physiopathology), Humans, Lymphangiosarcoma (diagnosis), Lymphangiosarcoma (etiology), Lymphangiosarcoma (physiopathology).
MESH :
- diagnosis : Hemangiosarcoma, Lymphangiosarcoma.
- etiology : Hemangiosarcoma, Lymphangiosarcoma.
- physiopathology : Hemangiosarcoma, Lymphangiosarcoma.
- Diagnosis, Differential, Humans.

Abstract

Stewart-Treves syndrome is a malignancy that arises within chronic lymphedema. Although classically described as a consequence of radical mastectomy, this lymphangiosarcoma has been documented to occur in cases of congenital and other causes of chronic secondary lymphedema. The development of this aggressive lymphangiosarcoma at sites of chronic lymphedema renders it a possible model for Kaposi sarcoma. Because of the increase in conservative treatment for breast carcinoma and improvement of operative and radiation therapy techniques, the prevalence of Stewart-Treves syndrome has decreased. Regardless, this malignancy significantly worsens patients' outcomes and needs to be diagnosed and treated early. Chemotherapy and radiation therapy have not improved survivorship significantly. Early amputation or wide local excision offers the best chance for long-term survival. Yet, overall prognosis remains dismal. Untreated patients usually live 5 to 8 months after diagnosis.

DOI: 10.1016/j.jaad.2012.04.028
PubMed: 22682884

Affiliations:

États-Unis

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Stewart-Treves syndrome: pathogenesis and management.</title>
<author><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
<affiliation wicri:level="1"><nlm:affiliation>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714</wicri:regionArea>
<wicri:noRegion>New Jersey 07103-2714</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22682884</idno>
<idno type="pmid">22682884</idno>
<idno type="doi">10.1016/j.jaad.2012.04.028</idno>
<idno type="wicri:Area/PubMed/Corpus">002089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002089</idno>
<idno type="wicri:Area/PubMed/Curation">002089</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002089</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002089</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002089</idno>
<idno type="wicri:Area/Ncbi/Merge">004E43</idno>
<idno type="wicri:Area/Ncbi/Curation">004E43</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004E43</idno>
<idno type="wicri:Area/Main/Merge">003E77</idno>
<idno type="wicri:Area/Main/Curation">003E64</idno>
<idno type="wicri:Area/Main/Exploration">003E64</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Stewart-Treves syndrome: pathogenesis and management.</title>
<author><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
<affiliation wicri:level="1"><nlm:affiliation>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Dermatology and Pathology, New Jersey Medical School, Newark, New Jersey 07103-2714</wicri:regionArea>
<wicri:noRegion>New Jersey 07103-2714</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</author>
</analytic>
<series><title level="j">Journal of the American Academy of Dermatology</title>
<idno type="eISSN">1097-6787</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Hemangiosarcoma (diagnosis)</term>
<term>Hemangiosarcoma (etiology)</term>
<term>Hemangiosarcoma (physiopathology)</term>
<term>Humans</term>
<term>Lymphangiosarcoma (diagnosis)</term>
<term>Lymphangiosarcoma (etiology)</term>
<term>Lymphangiosarcoma (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Humains</term>
<term>Hémangiosarcome (diagnostic)</term>
<term>Hémangiosarcome (physiopathologie)</term>
<term>Hémangiosarcome (étiologie)</term>
<term>Lymphangiosarcome (diagnostic)</term>
<term>Lymphangiosarcome (physiopathologie)</term>
<term>Lymphangiosarcome (étiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Diagnosis, Differential</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Diagnostic différentiel</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Stewart-Treves syndrome is a malignancy that arises within chronic lymphedema. Although classically described as a consequence of radical mastectomy, this lymphangiosarcoma has been documented to occur in cases of congenital and other causes of chronic secondary lymphedema. The development of this aggressive lymphangiosarcoma at sites of chronic lymphedema renders it a possible model for Kaposi sarcoma. Because of the increase in conservative treatment for breast carcinoma and improvement of operative and radiation therapy techniques, the prevalence of Stewart-Treves syndrome has decreased. Regardless, this malignancy significantly worsens patients' outcomes and needs to be diagnosed and treated early. Chemotherapy and radiation therapy have not improved survivorship significantly. Early amputation or wide local excision offers the best chance for long-term survival. Yet, overall prognosis remains dismal. Untreated patients usually live 5 to 8 months after diagnosis.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A" last="Schwartz">Robert A. Schwartz</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Sharma, Amit" sort="Sharma, Amit" uniqKey="Sharma A" first="Amit" last="Sharma">Amit Sharma</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E64 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003E64 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22682884
   |texte=   Stewart-Treves syndrome: pathogenesis and management.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22682884" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Stewart-Treves syndrome: pathogenesis and management.

Stewart-Treves syndrome: pathogenesis and management.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.